Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Safer hypoglycemic agents in the ADIR pipeline

Oct. 1, 2001

Another major European launch for enzyme therapy for use in tumor lysis syndrome

Oct. 1, 2001

Daiichi's new squalene synthase and cholesterol biosynthesis inhibitors patented

Sep. 28, 2001

Phosphonic acid-based inhibitors of FBPase synthesized at Metabasis

Sep. 27, 2001

First IND filed for product emerging from Lilly/Ligand metabolic disease collaboration

Sep. 27, 2001

Irbesartan gives renal protection in type 2 diabetes patients independent of blood pressure effect

Sep. 27, 2001

Bayer worldwide licensing offer

Sep. 27, 2001

Forbes' cholesterol-lowering pharmaceutical advances to clinical trials in Europe

Sep. 26, 2001

sBLA submitted for ARANESP

Sep. 25, 2001

Thyroid hormone receptor modulator commences human safety trials

Sep. 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.